Baby thyroid study: liquid medicine vs crushed pills

NCT ID NCT05228184

Terminated Disease control Sponsor: IBSA Institut Biochimique SA Source: ClinicalTrials.gov ↗

Summary

This study aimed to compare a liquid form of thyroid hormone medication (Tirosint-SOL) with the standard crushed tablet form for treating babies with congenital hypothyroidism. It involved about 126 infants up to 9 months old to see which treatment was easier for parents to give and better at keeping hormone levels stable. The trial was terminated early and followed babies for about a year.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States
Boston Children's Hospital

Boston, Massachusetts, 02115, United States
CHOC Children's Hospital

Orange, California, 92868, United States
Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States
Children's Hospital of Atlanta

Atlanta, Georgia, 30329, United States
Children's Hospital of Los Angeles

Los Angeles, California, 90027, United States
Children's Mercy Hospital and Clinics

Kansas City, Missouri, 64111, United States
Cook Children's Health Care Systems

Fort Worth, Texas, 76104, United States
University of California San Francisco

San Francisco, California, 94143, United States
Yale University

New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.

CONGENITAL HYPOTHYROIDISM